Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid

BACKGROUND: Bisphosphonates have a high adsorption on calcified tissues and are commonly used in the treatment of bone disorder diseases. Conjugates of bisphosphonates with macrocyclic chelators open new possibilities in bone targeted radionuclide imaging and therapy. Subsequent to positron emission...

Descripción completa

Detalles Bibliográficos
Autores principales: Meckel, M., Bergmann, R., Miederer, M., Roesch, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843815/
https://www.ncbi.nlm.nih.gov/pubmed/29564390
http://dx.doi.org/10.1186/s41181-016-0017-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843815/
https://www.ncbi.nlm.nih.gov/pubmed/29564390
http://dx.doi.org/10.1186/s41181-016-0017-1

Ejemplares similares